跳至主要内容
临床试验/NCT02105376
NCT02105376Unknown1 期

The Effects of Trigeminal Nerve Stimulation (TNS) for the Treatment of Major Depressive Disorder: a Phase II, Randomized, Sham Controlled Clinical Trial

Santa Casa Medical School2 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2014年5月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
44
试验地点
2
主要终点
Hamilton Depressive Rating Scale version 17 items (HDRS-17)

研究概览

简要总结

This is a phase II, randomized, sham controlled, clinical trial. This clinical trial has as primary objective to evaluate the effect of the Trigeminal Nerve Stimulation (TNS) on depressive symptoms measured by the Hamilton Depressive Rating Scale version 17 items (HDRS-17) in patients with moderate / severe depressive episode.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients between 18 and 69 years
  • patients with a diagnosis of depression according to the SCID
  • score greater than or equal to 18 on the Hamilton Rating Scale 17-item version (equivalent to moderate or severe depressive episode)
  • agreement to participate in the study as recommended in the IC.

排除标准

  • patients with psychiatric indication for hospitalization
  • patients with psychiatric comorbidity
  • patients with a diagnosis of personality disorder
  • presence of severe neurological or medical diseases such as neoplasms in activity, neurodegenerative diseases and chronic diseases uncompensated.

结局指标

主要结局

Hamilton Depressive Rating Scale version 17 items (HDRS-17)

时间窗: Change from baseline in depressive symptoms at 2 weeks

This clinical trial has as primary objective to evaluate the effect of the Trigeminal Nerve Stimulation (TNS) on depressive symptoms measured by the Hamilton Depressive Rating Scale version 17 items (HDRS-17) in patients with moderate / severe depressive episode.

次要结局

  • Montreal Cognitive Assessment (MOCA)(Change from baseline in cognitive functioning at 2 weeks)

研究者

发起方
Santa Casa Medical School
申办方类型
Other
责任方
Principal Investigator
主要研究者

Pedro Shiozawa

Pedro Shiozawa, Coordinator, Laboratory of Clinical Neuromodulation, Principal Investigator

Faculdade de Ciências Médicas da Santa Casa de São Paulo

研究点 (2)

Loading locations...

相似试验